Dr. John Carlise, editor-in-chief of the journal Anaesthesia and an anesthesiologist at Torbay Hospital in Torquay, U.K., published an analysis in June 2017, accusing NEJM — among other journals — of fabricating data. Dr. Carlisle reanalyzed 5,087 randomized trials published in eight health journals using statistical software. He found about 2 percent of the statistics used in these papers were questionable, including studies published in NEJM.
Just days after Dr. Carlise’s report was published, NEJM identified 11 of its articles with glaring issues. Six contained mistakes — five of which stemmed from a misunderstanding of statistical terms. The sixth study, a 2013 clinical trial suggesting a Mediterranean diet can help prevent heart disease, contained more serious errors.
“It turned out when we contacted the investigators, they had already been working on it, they had seen the same thing we had and been concerned,” NEJM Editor-in-Chief Jeffrey Drazen told Science.
After reanalyzing the data, researchers discovered the study’s findings still suggested a Mediterranean diet is beneficial to individuals with heart disease.
More aritlces on clinical leadership and infection control:
Legionella detected in California VA hospital’s water supply
Leapfrog disputes CMS’ plan to remove some safety, infection stats from quality reporting
AHRQ to shutter clearinghouse for evidence-based guidelines in July
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
